Hemab Appoints Mads Behrndt as Chief Financial Officer

Copenhagen, Denmark and Boston, US – 21 September 2021 Hemab ApS (“Hemab”), a biotech company developing next generation therapeutics for serious underserved bleeding and thrombosis disorders, today announces the appointment of Mads Behrndt as Chief Financial Officer.

Read more…

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...